Table 1 Patient characteristics
Persistent post-COVID-19 headache (n = 7) | Mild Neuro-COVID-19 (n = 5) | Control group headache (n = 5) | Control group facial paralysis (n = 5) | Control group MS/ON (n = 8) | Control group PD (n = 7) | Control group seizure (n = 5) | Control group psychiatric disease (n = 6) | |
|---|---|---|---|---|---|---|---|---|
Weeks since COVID-19 infection | 12 ± 12 | 0 ± 0 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
Age [years] | 40 ± 10 | 65 ± 8 | 28 ± 12 | 38 ± 18 | 42 ± 14 | 63 ± 13 | 42 ± 16 | 35 ± 13 |
Male | 1 (14%) | 3 (60%) | 3 (60%) | 4 (80%) | 5 (63%) | 7 (100%) | 4 (80%) | 6 (100%) |
Female | 6 (86%) | 2 (40%) | 2 (40%) | 1 (20%) | 3 (38%) | 0 (0%) | 1 (20%) | 0 (0%) |